ELEVAR THERAPEUTICS, INC.

ELEVAR

Pharmaceutical preparations, namely, experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients;The English translation of ELEVAR in the mark is to raise.;Research and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients;

ELEVAR

Educational services, namely, conducting classes, seminars, and workshops in cancer therapeutics; Medical training services; medical education not directed to retail pharmacies nor patients, namely, providing continuing medical education courses directed to medical professionals in the field of diagnosing and treating cancer disorders by a provider specializing in the research and development of experimental and novel cancer therapies;The mark consists of the stylized blue lowercase wording ELEVAR. Above the letters A and R is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.;Stress relief hand exercise balls; Sporting goods, namely, sports balls, hand stress balls, stress squeeze toy exercise balls, yoga balls, medicine balls, flying disks, flying disk rings, golf balls, golf tees and golf gloves;Novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer;Printed materials, namely, printed teaching materials and journals in the field of therapeutic treatments; printed materials, namely, brochures, booklets, newsletters and informational cards all in the fields of pharmaceutical and biotechnology research and development, medical conditions, vaccinations, disease prevention and treatments; printed medical journals and printed magazines for oncology health practitioners all featuring clinical trials and research and information related to the diagnosis and treatment of conditions related to oncology; paper goods, namely, stationery, industrial corrugated paper, cardboard, construction paper, paper boards and coasters of paper; Writing pads and prescription reminder pads; Writing implements;Clothing, namely, shirts, t-shirts, vests, sweaters, headwear, wrist bands, gloves, socks, and jackets, all of the foregoing distributed primarily to medical professionals who treat cancer;The color(s) blue, light blue and dark blue is/are claimed as a feature of the mark.;Information services, namely, providing consumer product information for medical professionals in the field of cancer and cancer treatment via a global computer network;The English translation of the word ELEVAR in the mark is to raise.;Chemotherapy services;Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments;

ELEVAR

Printed materials, namely, printed teaching material in the field of therapeutic treatments, journals featuring therapeutics, brochures, booklets, newsletters and informational cards in the fields of research and development in the pharmaceutical and biotechnology fields, medical conditions, vaccinations, prevention of diseases and treatments; Medical journals and magazines for oncology health practitioners featuring news, updated information on clinical research and trials, and practical information related to the diagnosis and treatment of conditions related to oncology; paper goods, namely, Stationery and industrial paper and cardboard, construction paper, paper boards, coasters of paper; Writing pads and prescription pads; Writing implements;The English translation of ELEVAR in the mark is TO RAISE.;

ELEVAR

Stress relief hand exercise balls; Sporting goods, namely, sports balls, hand stress balls, stress squeeze toy exercise balls, yoga balls, medicine balls, flying disks, flying rings, golf balls, golf tees and golf gloves;The English translation of ELEVAR in the mark is TO RAISE.;

ELEVAR

Educational services in connection with cancer therapeutics, namely, providing classes, seminars, workshops, in the field of cancer therapeutics to health care professionals;The English translation of ELEVAR in the mark is TO RAISE.;

ELEVAR

The English translation of ELEVAR in the mark is TO RAISE.;Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily in promotion of cancer treatments to healthcare professionals;

ELEVAR

The English translation of ELEVAR in the mark is TO RAISE.;Beverageware;

ELEVAR

Clothing, namely, shirts, t-shirts, vests, sweaters, headwear, wrist bands, gloves, socks, and jackets, all of the foregoing distributed primarily to medical professionals in promotion of treatments for cancer;The English translation of ELEVAR in the mark is TO RAISE.;

ELEVAR THERAPEUTICS

Educational services, namely, conducting classes, seminars, and workshops in cancer therapeutics; Medical training services; medical education not directed to retail pharmacies nor patients, namely, providing continuing medical education courses directed to medical professionals in the field of diagnosing and treating cancer disorders by a provider specializing in the research and development of experimental and novel cancer therapies;The mark consists of the stylized blue lowercase wording ELEVAR above the stylized gray lowercase wording THERAPEUTICS. Above the letters A and R in ELEVAR is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.;Stress relief hand exercise balls; Sporting goods, namely, sports balls, hand stress balls, stress squeeze toy exercise balls, yoga balls, medicine balls, flying disks, flying disk rings, golf balls, golf tees and golf gloves;Novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer;Printed materials, namely, printed teaching materials and journals in the field of therapeutic treatments; printed materials, namely, brochures, booklets, newsletters and informational cards all in the fields of pharmaceutical and biotechnology research and development, medical conditions, vaccinations, disease prevention and treatments; printed medical journals and printed magazines for oncology health practitioners all featuring clinical trials and research and information related to the diagnosis and treatment of conditions related to oncology; paper goods, namely, stationery, industrial corrugated paper, cardboard, construction paper, paper boards and coasters of paper; Writing pads and prescription reminder pads; Writing implements;Clothing, namely, shirts, t-shirts, vests, sweaters, headwear, wrist bands, gloves, socks, and jackets, all of the foregoing distributed primarily to medical professionals who treat cancer;The color(s) blue, light blue, dark blue and gray is/are claimed as a feature of the mark.;Information services, namely, providing consumer product information for medical professionals in the field of cancer and cancer treatment via a global computer network;The English translation of the word ELEVAR in the mark is to raise.;Chemotherapy services;THERAPEUTICS;Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments;

TULVEGIO

pharmaceutical preparations and substances for the treatment of cancer;

TULVEGIO RIVOCERANIB

The mark consists of the stylized upper-case wording TULVEGIO above the stylized lowercase wording RIVOCERANIB. To the left of the letter T is the stylized design of a hand tilted toward the letter T.;Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer;Color is not claimed as a feature of the mark.;Marketing in the field of cancer treatments containing rivoceranib;The wording TULVEGIO RIVOCERANIB has no meaning in a foreign language.;RIVOCERANIB;Development of therapeutics for the treatment of cancer containing rivoceranib;